N/A
Average AnalystN/A
Top AnalystVery Bearish
Stock Target AdvisorN/A
Average UserUSD 0.05
-0.03 (-35.90%)
USD 0.11M
0.06M
USD 0.00
Based on the Mycotopia Therapies Inc stock forecast from 0 analysts, the average analyst target price for Mycotopia Therapies Inc is not available over the next 12 months. Mycotopia Therapies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Mycotopia Therapies Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Mycotopia Therapies Inc’s stock price was USD 0.05. Mycotopia Therapies Inc’s stock price has changed by -39.02% over the past week, +104.08% over the past month and +284.62% over the last year.
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock is trading high compared to its peers median on a price to book value basis.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company had negative total cash flow in the most recent four quarters.
The company had negative total free cash flow in the most recent four quarters.
This stock has shown below median earnings growth in the previous 5 years compared to its sector